Be Ready to Dispense Paxlovid or Molnupiravir for COVID-19

You'll start to see Rxs for two new oral antivirals to treat COVID-19, Paxlovid (nirmatrelvir/ritonavir) or molnupiravir.

Either is an option for patients with mild to moderate COVID-19 who are at high risk of developing serious illness (age 65 or older, diabetes, etc)...regardless of vaccination status.

Be ready to handle these Rxs correctly...and ensure safe use.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote